Irinotecan and carboplatin (IC) regimen for small-cell lung cancer and non-small-cell lung cancer

Matthew R. Rutledge, James Waddell, Dominic A. Solimando

Research output: Contribution to journalArticle

Abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

Original languageEnglish (US)
Pages (from-to)603-611
Number of pages9
JournalHospital Pharmacy
Volume49
Issue number7
DOIs
StatePublished - Jan 1 2014

Fingerprint

irinotecan
Poisons
Carboplatin
Small Cell Lung Carcinoma
Pharmacists
Non-Small Cell Lung Carcinoma
Antineoplastic Agents
Cells
Drug Therapy
Chemotherapy
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmacology (medical)

Cite this

Irinotecan and carboplatin (IC) regimen for small-cell lung cancer and non-small-cell lung cancer. / Rutledge, Matthew R.; Waddell, James; Solimando, Dominic A.

In: Hospital Pharmacy, Vol. 49, No. 7, 01.01.2014, p. 603-611.

Research output: Contribution to journalArticle

Rutledge, Matthew R. ; Waddell, James ; Solimando, Dominic A. / Irinotecan and carboplatin (IC) regimen for small-cell lung cancer and non-small-cell lung cancer. In: Hospital Pharmacy. 2014 ; Vol. 49, No. 7. pp. 603-611.
@article{732cdf6c85b74c8798d70cf6c93b6d57,
title = "Irinotecan and carboplatin (IC) regimen for small-cell lung cancer and non-small-cell lung cancer",
abstract = "The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.",
author = "Rutledge, {Matthew R.} and James Waddell and Solimando, {Dominic A.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1310/hpj4907-603",
language = "English (US)",
volume = "49",
pages = "603--611",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "7",

}

TY - JOUR

T1 - Irinotecan and carboplatin (IC) regimen for small-cell lung cancer and non-small-cell lung cancer

AU - Rutledge, Matthew R.

AU - Waddell, James

AU - Solimando, Dominic A.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

AB - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

UR - http://www.scopus.com/inward/record.url?scp=84905404131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905404131&partnerID=8YFLogxK

U2 - 10.1310/hpj4907-603

DO - 10.1310/hpj4907-603

M3 - Article

VL - 49

SP - 603

EP - 611

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 7

ER -